Related Experiment Video
Updated: Aug 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways
Eiichiro Yumoto1, Harushige Nakatsukasa, Tadashi Hanafusa
1Department of Medicine, Okayama University Graduate School of Medicine and Dentistry, Japan. yumoto-gi@umin.ac.jp
Abstract:
Insulin-like growth factor binding protein-3 (IGFBP-3) is a mediator of growth suppression signals and a putative tumor suppressor gene. The growth suppression mechanisms of IGFBP-3 have not been well clarified. We examined the expression of IGFBP-3 transcripts in human hepatocellular carcinoma (HCC) and the relationship between IGFBP-3 expression and the transforming growth factor-beta (TGF-beta) and/or retinoblastoma (Rb) signaling pathways. In situ hybridization revealed IGFBP-3 transcripts in cancer cells in 6 of 57 (10%) HCCs, including moderately and poorly differentiated HCCs with intrahepatic metastasis. In contrast, all lung metastatic nodules of 4 HCCs showed IGFBP-3 transcripts in cancer cells. The cDNA microarray showed that genes for the TGF-beta pathway and Rb were up-regulated in IGFBP-3-expressing HCCs. In 6 HCCs presenting IGFBP-3, immunohistochemical analyses showed abnormalities in the TGF-beta and/or Rb pathways; the loss of phosphorylated-Smad2 was observed in 2, and overexpression of phosphorylated-Rb was observed in the remaining 4 HCCs. The present study suggests that IGFBP-3 mediates growth suppression signals via the TGF-beta and/or Rb pathways in HCC.
Insights
Insulin-like growth factor binding protein-3 (IGFBP-3) acts as a tumor suppressor in hepatocellular carcinoma (HCC). This study reveals IGFBP-3 activates growth suppression pathways, including TGF-beta and Rb, in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Insulin-like growth factor binding protein-3 (IGFBP-3) is recognized for its role in mediating growth suppression and as a potential tumor suppressor gene.
- The precise mechanisms by which IGFBP-3 exerts its growth-suppressive effects remain incompletely understood, particularly in the context of hepatocellular carcinoma (HCC).
Purpose of the Study:
- To investigate the expression patterns of IGFBP-3 transcripts in human HCC.
- To elucidate the relationship between IGFBP-3 expression and the transforming growth factor-beta (TGF-beta) and retinoblastoma (Rb) signaling pathways in HCC.
Main Methods:
- In situ hybridization was employed to detect IGFBP-3 transcripts in HCC tissues and metastatic nodules.
- cDNA microarray analysis was performed to assess gene expression profiles in IGFBP-3-expressing HCCs.
- Immunohistochemical analyses were conducted to evaluate the status of TGF-beta and Rb pathway components.
Main Results:
- IGFBP-3 transcripts were detected in 10% of HCCs (6/57), predominantly in moderately/poorly differentiated tumors with intrahepatic metastasis, and consistently in lung metastatic nodules.
- cDNA microarray data indicated upregulation of TGF-beta and Rb pathway genes in HCCs expressing IGFBP-3.
- Immunohistochemistry revealed pathway abnormalities: loss of phosphorylated-Smad2 in 2 cases and overexpression of phosphorylated-Rb in 4 cases among the 6 HCCs with IGFBP-3.
Conclusions:
- The findings suggest that IGFBP-3 plays a role in mediating growth suppression signals in HCC.
- IGFBP-3 appears to exert its effects through the TGF-beta and/or Rb signaling pathways.
- Further research into IGFBP-3's function could offer novel therapeutic strategies for HCC.
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
